Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Advanced Gastric Cancer × Ipilimumab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Melanoma 93 Carcinoma, Non-Small-Cell Lung 30 Carcinoma, Renal Cell 21 Prostatic Neoplasms 14 Neoplasm Metastasis 14 Brain Neoplasms 12 Neoplasms 11 Lung Neoplasms 11 Breast Neoplasms 11 Uveal Melanoma 9 Sarcoma 9 Pancreatic Neoplasms 9 Small Cell Lung Carcinoma 7 Urinary Bladder Neoplasms 6 Kidney Neoplasms 6 Carcinoma, Transitional Cell 6 Carcinoma, Hepatocellular 6 Squamous Cell Carcinoma of Head and Neck 5 Skin Neoplasms 5 Ovarian Neoplasms 5 Diabetes Mellitus, Insulin-Dependent, 12 5 Colorectal Neoplasms 5 Uterine Cervical Neoplasms 4 Triple Negative Breast Neoplasms 4 Histiocytoma, Malignant Fibrous 4 Colonic Neoplasms 4 Urogenital Neoplasms 3 Recurrence 3 Rectal Neoplasms 3 Osteosarcoma 3

Interventions

Oxaliplatin 5 Capecitabine 5 Paclitaxel 4 Fluorouracil 3 Docetaxel 3 Cisplatin 3 apatinib 2 S 1 (combination) 2 Leucovorin 2 titanium silicide 1 rucaparib 1 relatlimab 1 raltitrexed 1 pazopanib 1 olaparib 1 linrodostat 1 endostar protein 1 durvalumab 1 dacomitinib 1 capivasertib 1 camrelizumab 1 Sunitinib 1 Nivolumab 1 Ipilimumab 1 HMPL-013 1 Epirubicin 1 CF regimen 1 Bevacizumab 1 130-nm albumin-bound paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02935634 2023-06-09

FRACTION-GC

Bristol-Myers Squibb

Phase 2 Completed

190 enrolled 25 charts

Gastrointestinal

Advanced Gastric Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡